253 related articles for article (PubMed ID: 15864383)
1. So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity.
Chang A; Schuetze SM; Conrad EU; Swisshelm KL; Norwood TH; Rubin BP
Int J Surg Pathol; 2005 Apr; 13(2):185-95. PubMed ID: 15864383
[TBL] [Abstract][Full Text] [Related]
2. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
[TBL] [Abstract][Full Text] [Related]
4. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma.
Merchant W; Calonje E; Fletcher CD
Histopathology; 1995 Dec; 27(6):525-32. PubMed ID: 8838332
[TBL] [Abstract][Full Text] [Related]
7. [Leiomyosarcoma with prominent osteoclast-like giant cells: a clinicopathologic analysis of 7 cases and review of literature].
Li Y; Xu XL; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):363-7. PubMed ID: 21914342
[TBL] [Abstract][Full Text] [Related]
8. Vascular leiomyosarcoma: Clinicopathology and immunohistochemistry with special reference to a unique smooth muscle phenotype.
Matsuyama A; Hisaoka M; Hashimoto H
Pathol Int; 2010 Mar; 60(3):212-6. PubMed ID: 20403047
[TBL] [Abstract][Full Text] [Related]
9. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
[TBL] [Abstract][Full Text] [Related]
10. Primary leiomyosarcoma of bone--a clinicopathologic study of 8 uncommon cases with immunohistochemical analysis and clinical outcomes.
Rekhi B; Kaur A; Puri A; Desai S; Jambhekar NA
Ann Diagn Pathol; 2011 Jun; 15(3):147-56. PubMed ID: 21393038
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
12. Primary leiomyosarcoma of the pancreas: study of 9 cases and review of literature.
Zhang H; Jensen MH; Farnell MB; Smyrk TC; Zhang L
Am J Surg Pathol; 2010 Dec; 34(12):1849-56. PubMed ID: 21107091
[TBL] [Abstract][Full Text] [Related]
13. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
14. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma.
Magro G; Gurrera A; Bisceglia M
Histopathology; 2003 Mar; 42(3):233-8. PubMed ID: 12605642
[TBL] [Abstract][Full Text] [Related]
15. Primary Leiomyosarcoma of the Ovarian Vein: Case Report and Literature Review.
López-Ruiz ME; Yébenes L; Berjón A; Hardisson D
Int J Surg Pathol; 2017 Jun; 25(4):339-343. PubMed ID: 27881610
[TBL] [Abstract][Full Text] [Related]
16. A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle cell neoplasms.
Beck EM; Bauman TM; Rosman IS
J Cutan Pathol; 2018 Aug; 45(8):581-587. PubMed ID: 29687929
[TBL] [Abstract][Full Text] [Related]
17. Primary ovarian leiomyosarcoma. An immunohistochemical and ultrastructural study.
Friedman HD; Mazur MT
Arch Pathol Lab Med; 1991 Sep; 115(9):941-5. PubMed ID: 1929791
[TBL] [Abstract][Full Text] [Related]
18. Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases.
de Saint Aubain Somerhausen N; Fletcher CD
Am J Surg Pathol; 1999 Jul; 23(7):755-63. PubMed ID: 10403297
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
Bodner K; Bodner-Adler B; Czerwenka K; Hudelist G; Kimberger O; Leodolter S; Mayerhofer K
Wien Klin Wochenschr; 2003 Mar; 115(5-6):191-5. PubMed ID: 12741081
[TBL] [Abstract][Full Text] [Related]
20. Characterization of giant marker and ring chromosomes in a pleomorphic leiomyosarcoma of soft tissue by spectral karyotyping.
Nishio J; Aoki M; Nabeshima K; Iwasaki H; Naito M
Oncol Rep; 2012 Aug; 28(2):533-8. PubMed ID: 22641359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
